Screening and diagnosis of congenital cytomegalovirus infection: a 5-y study.
Although cytomegalovirus infection is the most common infection transmitted via the placenta, there are no guidelines for routine screening to detect children congenitally infected with cytomegalovirus. From 1993 to 1997, maternal serum and cord vein blood of newborns was screened for HCMV-IgM (n = 21,183). Urine was examined for HCMV-excretion during the first postnatal week to prove HCMV infection in children who expressed HCMV-IgM in cord vein blood (n = 13) or who were born to mothers positive for HCMV-IgM in the serum (n = 234), or when both cord vein blood and maternal serum were positive for HCMV-IgM (n = 6). Congenital HCMV infection was detected in 17 newborns. To determine the incidence of congenital HCMV infection, only those mother/child pairs were selected in whom serum and cord vein blood were investigated (n = 5967 mother/child pairs). In this group 13 newborns were infected. The observed incidence for congenital HCMV infection is 0.21%. It is concluded that that this screening programme will detect those children at risk for congenital HCMV infection. These children have to be examined for virus excretion in the urine. Although the observed incidence is only 0.21%, congenital HCMV infection is a problem that can no longer be neglected because of its long-term sequelae.
Halwachs-Baumann
G
G
Gemeinsame Einrichtung für Medizinisch-Chemische Labordiagnostik der Karl-Franzens-Universität Graz, Austria.
Genser
B
B
Danda
M
M
Engele
H
H
Rosegger
H
H
Fölsch
B
B
Maurer
U
U
Lackner
H
H
Truschnig-Wilders
M
M
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use; D001317:Austria / Q000453:epidemiology; D002555:Cerebrospinal Fluid / Q000821:virology; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000453:epidemiology / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005312:Fetal Blood / Q000821:virology; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D015994:Incidence; D007231:Infant, Newborn; D015997:Neonatal Screening; D014556:Urine / Q000821:virology
D000914:Antibodies, Viral; D000998:Antiviral Agents; D004279:DNA, Viral; D007075:Immunoglobulin M; D015774:Ganciclovir